Suppr超能文献

慢性阻塞性肺疾病管理。

Management of Chronic Obstructive Pulmonary Disease.

机构信息

Belgorod State National Research University, 85 Pobedy St., Belgorod 308015 Russia.

Voronezh State Medical University named after N.N. Burdenko, 10 Studencheskaya St., Voronezh 394036 Russia.

出版信息

Arch Razi Inst. 2022 Feb 28;77(1):439-447. doi: 10.22092/ARI.2021.356613.1882. eCollection 2022 Feb.

Abstract

The relevance of the study of chronic obstructive pulmonary disease (COPD) can be explained by the persistence of unfavorable dynamics of the disease, even despite the achieved success in the pharmacotherapy of this pathology. In 2016, World Health Organization (WHO) ranked COPD as the third leading cause of death worldwide, far exceeding the experts' predictions, who believed that such an increase in the death rate would occur by 2030. This study aimed to determine the level of senior medical students' knowledge in the management of patients with COPD, based on the method of anonymous questioning. This research work describes the results of the second stage of the ASCO project (Assessment of Senior Medical Students in the Field of COPD) conducted in 2017-2019 among 338 senior medical students from six large cities of Russia and Ukraine. The survey revealed the average level of knowledge among senior medical students, based on the average level of correct answers (56.6%) obtained in the study. The best results were obtained for the questions about COPD risk factors, influenza vaccine prevention, and pneumococcal vaccine prevention in COPD patients. The worst results were recorded on the questions about the severity of COPD clinical symptoms, the choice of initial therapy for COPD with advanced symptoms, a high risk of exacerbations, and the moderate exacerbation of COPD. The obtained results indicated an insufficient level of students' basic knowledge in questions regarding etiopathogenesis, diagnosis, treatment, and prevention of COPD.

摘要

慢性阻塞性肺疾病(COPD)研究的相关性可以用该疾病的不利动态持续来解释,尽管在这种病理的药物治疗方面已经取得了成功。2016 年,世界卫生组织(WHO)将 COPD 列为全球第三大死亡原因,远远超出了专家的预测,专家们认为这种死亡率的增加将在 2030 年发生。本研究旨在基于匿名提问的方法,确定高年级医学生在 COPD 患者管理方面的知识水平。这项研究工作描述了 2017 年至 2019 年在俄罗斯和乌克兰的六个大城市的 338 名高年级医学生中进行的 ASCO 项目(COPD 高年级医学生评估)第二阶段的结果。该调查根据研究中获得的平均正确答案(56.6%)得出了高年级医学生的平均知识水平。在 COPD 风险因素、流感疫苗预防和 COPD 患者中肺炎球菌疫苗预防的问题上,取得了最好的结果。在 COPD 临床症状严重程度、晚期 COPD 初始治疗选择、高恶化风险和 COPD 中度恶化等问题上,记录的结果最差。所获得的结果表明,学生在 COPD 的病因学、诊断、治疗和预防方面的基础知识水平不足。

相似文献

1
Management of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病管理。
Arch Razi Inst. 2022 Feb 28;77(1):439-447. doi: 10.22092/ARI.2021.356613.1882. eCollection 2022 Feb.
6
Understanding of COPD among final-year medical students.医学专业最后一年学生对慢性阻塞性肺疾病(COPD)的了解。
Int J Chron Obstruct Pulmon Dis. 2017 Dec 28;13:131-139. doi: 10.2147/COPD.S138539. eCollection 2018.

本文引用的文献

2
Smoking Cessation During the COVID-19 Epidemic.新冠疫情期间的戒烟
Nicotine Tob Res. 2020 Aug 24;22(9):1664-1665. doi: 10.1093/ntr/ntaa075.
4
Choosing the right inhaler for your asthma or COPD patient.为您的哮喘或慢性阻塞性肺疾病患者选择合适的吸入器。
Ther Clin Risk Manag. 2019 Mar 14;15:461-472. doi: 10.2147/TCRM.S160365. eCollection 2019.
6
Pneumococcal vaccination and chronic respiratory diseases.肺炎球菌疫苗接种与慢性呼吸系统疾病。
Int J Chron Obstruct Pulmon Dis. 2017 Dec 5;12:3457-3468. doi: 10.2147/COPD.S140378. eCollection 2017.
8
The Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的药物治疗
Dtsch Arztebl Int. 2016 May 6;113(18):311-6. doi: 10.3238/arztebl.2016.0311.
10
Exacerbations of COPD.慢性阻塞性肺疾病急性加重
Int J Chron Obstruct Pulmon Dis. 2016 Feb 19;11 Spec Iss(Spec Iss):21-30. doi: 10.2147/COPD.S85978. eCollection 2016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验